Education/ Training
1992- Ph.D. Nutritional Biochemistry
1991-1994- Post Doctoral Fellow; Biochemistry
Honors/ Awards
NIH Traineeship: Center for Human Nutrition, UCHSC, 1992-1993.
The Amyotrophic Lateral Sclerosis Association, 1994-1996.
Center for Human Nutrition, UCHSC, Pilot and Feasibility Study, 1996-1998.
SangStat, a Transplant Company, Preclinical study, 1997.
The American Heart Association, Grant-in-aid, 1998-1999.
The American Heart Association, Scientist Development Grant, 2001-2005.
Herrick Scientist Development Grant, 2001-2004.
Professional Experience
Jan 2006-Present: Associate Clinical Professor of Medicine
Division of Pulmonary Sciences and Critical Care Medicine
UCDENVER
Jan 2006-2007 Science Coordinator
LifeLine Therapeutics
Denver, CO
June 2007-present Senior Scientist
SomaLogic, inc.
Boulder, CO
June 2001 to Jan 2006: Assistant Professor of Medicine
Webb-Waring Institute
UCHSC
June 1999 to present: Medical Advisory Committee
The Muscular Dystrophy Association
Tuscon, Arizona
July 1994 to June 2001: Instructor
Webb-Waring Institute,
UCHSC
INVITED SPEAKER AT:
Second International Symposium on Atherosclerosis, Thrombosis & Transfusion Medicine, Bangalore, India, 1996.
Emerging Potentials in Antioxidant Therapy, Goa, India, 1999.
University of Linkoping, Sweden, 2001.
South Asian Society for Atherosclerosis and Thrombosis, Madras, India, 2002.
Cardiothoracic Transplantation, An International Update, Vail, CO, 2003.
Colorado Oxygen Radical Society, Colorado, 2004.
3rd International Conference on Superoxide Dismutases, Paris, France, 2004.
Department of Pharmacy, University of Cardiff, Wales, May 2005.
Asian Institute of Gastroenterology, Hyderabad, India, Dec. 2005.
Research Interests
Extensively trained in free radical biochemistry and as it relates to diseases that have an oxidative stress component. Areas of research interests include aging, Heart/organ preservation and Transplantation chemistry, Amyotrophic Lateral Sclerosis (Lou Gehrigs disease), Pre-eclampsia, Diabetes and Heart Disease. Aptamer proteomics and biomarker discovery in neurological diseases which include Muscular Dystrophy, Multiple Sclerosis, Amyotrophic Lateral Sclerosis, Parkinson’s Disease, Alzheimer’s Disease, Depression, Fibromyalgia and Autism.
